AHPA keeps members and the industry informed of recent news and developments that impact the trade through email alerts. Subscribe to news as it happens or a weekly summary of all alerts.
View recent alerts:
Subscribe to AHPA Updates to stay informed about the latest AHPA news and resources.
Published: Wednesday, April 10, 2019
Event date: 5/16/2019 8:30 AM - 4:00 PM Export event
The U.S. Food and Drug Administration (FDA) is announcing a public meeting entitled “Responsible Innovation in Dietary Supplements”. On February 11, 2019, the FDA announced new efforts to strengthen the regulation of dietary supplements by modernizing and reforming its oversight. The purpose of the public meeting is to give interested parties an opportunity to present ideas for facilitating responsible innovation in the dietary supplement industry while preserving the FDA's ability to protect the public from unsafe, misbranded, or otherwise unlawful dietary supplements.
May 16, 2019
8:30am - 4:00pm
Center for Food Safety and Applied Nutrition
U.S. Food and Drug Administration
5001 Campus Drive
College Park, MD 20740
Public meeting attendees are encouraged to register online to attend the meeting in person or to participate via webcast. For general questions about the meeting or to request special accommodations due to a disability, contact Juanita Yates, Center for Food Safety and Applied Nutrition (HFS-009), Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, phone: 240-402-1731, email: Juanita.Yates@fda.hhs.gov.
For more information about the meeting, as well as instructions on registration and requesting to make an oral presentation, see the Federal Register notice about the meeting and the additional links provided below.
Number of Seats:
Click on these links to see a filtered list of alerts in one of these four topic areas
2019 Annual Fund Sponsors
AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.